Abstract:Objectives This study aimed to investigate the efficacy in patients with acute coronary syndrome using high-dose statins during the period of hospitalization as well as to observe the security.Methods A total of 67 selected patients are enrolled In this study.Patients are randomly divided into high-dose atorvastatin(n=41) and low-dose atorvas-tatin (n=26).We choose 5-day for the period of observation in this study.We give atorvastatin-20 mg per night for maintenance therapy in low-dose atorvastatin group.We give ator-vastatin -80 mg per night for maintenance therapy for 5-say and 20 mg per night from the 6th day in high-dose atorvastatin. Conventional therapy is given according to the patients situation and low-salt low-fat diet is given.UA、CRP and Fbg are measured at baseline and at 24 hours and? after 5-day. Lipid,liver function and renal function are measured at the 2nd day and the 6th day.Results(1)The two groups are similar with UA,CRP and Fbg at the time of procedural. The decline of UA,CRP are significantly more in two groups at 24-hours(P<0.001);but Fbg has no decline.The decline of UA:7.0%vs.10.4%(P=0.060),CRP:32.2%vs.42.5% (P=0.012),UA and CRP are both lower than at 24-hour in two groups(P<0.001),the decline of UA:10.9%vs.14.9% (P=0.259),CRP:76.3%vs.84.9%(P=0.035),Fbg is higher than at 24-hour in two groups,but has no significantly in two groups 37.7%vs.38.4%(P=0.700).(2) At 5-day clinical follow-up,3.8%of the cases occured MACE in placebo and 0%in atotvastatin group(3.8%vs.0%,P= 0.016),the other adverse events(9.6%vs.1.8%,P=0.004). TC,TG and HDL have no significant change,LDL decline in two groups,but has no difference between groups.(3) 8 patients have a increase in ALT after 5-day in low-dose atotvastatin group and 21 in high-dose atotvastatin group(31% vs.51%,P=0.059),no patient quit the research because ALT increase>3times.Both groups have a increase in BUN and Crs(BUN 46%vs.66%,P=0.057,Crs 58%vs.77%,P= 0.055).Conclutions(1)Early use of high-dose atorvastadn in ACS can reduce uric acid and c-reactive protein.Fbg has a ascent with the period of treatment.(2) Taking high-dose of atorvastatin in patients with ACS during hospitalization reduce the occurrence of MACE better than taking low-dose, and has nothing to do with lipid-lowing effect.(3) The use of high dose atorvastatin does not reduce drug use safety.

Impact of Early Statin Therapy on Inhospital and Follow-Up Outcomes for Acute Coronary Syndrome Patients Undergoing Revascularization

Effect of Early Statins Treatment on Patients with Percutaneous Coronary Intervention in Prognosis

The Effect and Underlying Mechanism of Statins in the Prevention of Post-Contrast Acute Kidney Injury: A Multicenter Retrospective Observational Study

The Effect of In-Hospital High-Dose Vs. Low-Dose Intensive Statin in Patients with Non-St Segment Elevation Acute Coronary Syndrome

Early Statin Therapy and In-Hospital Outcomes in Acute Coronary Syndrome Patients Presenting with Advanced Killip Class at Admission: Findings from the CCC-ACS Project

Benefits of Very Early Administration of Statins During the First Day of Hospitalization in Patients with Acute Myocardial Infarction

Efficacy and Safety of Serial Atorvastatin Load in Chinese Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ISCAP (intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) Randomized Controlled Trial

Early and extensive use of statins in patients with acute coronary syndrome

Long-term Statin Use Before Primary Percutaneous Coronary Intervention Improves Treatment Outcomes of Acute Myocardial Infarction

The effect of pre-hospital statins therapy on incidence of in-hospital death and total MACCE in patients with PCI.

Association between statin therapy and long-term clinical outcomes in patients with stable coronary disease undergoing percutaneous coronary intervention

The impact of aggressive statin treatment prior to percutaneous coronary intervention on patients with non-ST segment elevation acute coronary syndrome on cardiovascular events

Associations of Pre-Hospital Statin Treatment with In-Hospital Outcomes and Severity of Coronary Artery Disease in Patients with First Acute Coronary Syndrome-Findings from the CCC-ACS Project

The Effect of Early and Intensive Statin Therapy on Ventricular Premature Beat or Non-Sustained Ventricular Tachycardia in Patients with Acute Coronary Syndrome.

Prescription of Statins at Discharge and 1‐year Risk of Major Clinical Outcomes among Acute Coronary Syndromes Patients with Extremely Low LDL‐cholesterol in Clinical Pathways for Acute Coronary Syndromes Studies

Efficacy and Safety of Short-Term Intensive Statin Therapy in Patients with Acute Coronary Syndrome

Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project.

Effect of Statins Therapy Prior to Percutaneous Coronary Intervention

Association Between Statin Use and the Prognosis of Patients with Acute Myocardial Infarction Complicated with Diabetes.

Effect of high dose statin pretreatment for percutaneous coronary intervention patients with acute coronary syndrome

Impact of intensified statin therapy prior to percutaneous coronary intervention on high-sensitivity Creactive protein and von willebrand factor in patients with non-ST segment elevation acute coronary syndrome